We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Anyone any thoughts on why this has lost 15% in the last month pls? Can't see any obvious reason for it. Thanks in advance.
Just noticed that they might be selling one of there divisions might allow them to make a higher bid than last years!
What timeframe is there on when they can make a new bid?
and another from Barclays today - 3.10
JPMorgan raises Spire Healthcare price target to 347 (296) pence - 'overweight'
Director buys and Tosca fund adding last Friday. From memory, Tosca were one of the shareholders who rejected the takeover last year.
Full year results released today and despite COVID 19 cost pressure it's been announced that there has been a 10 % increase in Ebitda growth.
The main reason for this is due to people deciding to pay for their own procedures rather than lengthy waits for Nhs appointments. Lots more people also taking out private medical insurance so expect business to grow in the medium and long term as well.
Exciting times if you are invested here.
Gla.
Why?
Despite the notion that private can fill the gap in the NHS, I think what matters is the bottom line. Spire isn't that profitable and is warning of increasing costs. They can't simply raise prices as most people aren't rolling in money.
The whole market seems to have switched to companies that are reliably making money.
It looks like BOFA has been building a stake this month, however.
...revealed record NHS waiting lists, high caseloads and severe staffing shortages. It warned that a major expansion of the labor force was needed in health care but that the government was not doing enough to recruit and train.
An enormous and growing backlog of patients in Britain’s free health service has led to delays or diversions in planned care, in part because of the pandemic — a largely unseen crisis within a crisis. The problems are likely to have profound consequences that will be felt for years.
In England, nearly six million procedures are currently delayed, up from 4.6 million before the pandemic, according to the N.H.S. — and most likely representing almost one-tenth of the population. Hundreds of thousands more people haven’t yet been referred for treatment, and many ailments have simply gone undiagnosed.
Experts say that severe staffing shortages this winter and the wildfire spread of the Omicron variant have almost certainly made the situation worse. Public health experts now worry that even if the pandemic eases and relieves some of the immediate burden, the pandemic and delayed care could do lasting harm to the health system, as well as to patients.
https://www.nytimes.com/2022/01/26/world/europe/coronavirus-uk-nhs-backlog.html?campaign_id=51&emc=edit_mbe_20220127&instance_id=51419&nl=morning-briefing%3A-europe-edition®i_id=82323587&segment_id=80874&te=1&user_id=aa651dd6ef3f19859156d9557dc3264c
What's going on here? Surely Spire should be booming?
Self funding for treatment is booming, rather than waiting a long time with the NHS.
I think 350p trading range, a bidder would have to pay 400p.
https://www.fool.co.uk/2021/12/19/2-of-the-best-uk-shares-to-buy-for-2022/
I can see this being a takeover target again. Business is only going to improve because of NHS backlog.
BARCLAYS RAISES SPIRE HEALTHCARE PRICE TARGET TO 300 (280) PENCE - 'OVERWEIGHT'
Needs to in the absence of a dividend. We need to have capital gains & a plan for spending the profit otherwise somebody else will be in for a quick buck. Needs to be trading £2.89 plus so that any offers need to be closer to £3.50 to be considered.
Looks like a steady rise here, perhaps another bid? Anyway SPI are going to be very busy for the next 5 years with the state of the NHS. The largest play on the private healthcare market in the UK.
Mediclinic reported a 12% rise in revenue for the first half, while group EBITDA margins recovered to 15.5% from 12.1% a year ago
Has everyone gone on holiday, or in hospital!?
Does seem a very logical argument. No brainer really. The NHS has zero capacity to meet the demand pre covid, it has now got a while lot worse so Spire will mop that up all day long. I couldn't understand why they were ever going to sell at such a low price. Well....I could but it was only board payouts and bonuses nothing in the interest of us normal shareholders. This should be closer to 4 pounds per share in the next 12 months
Spire Healthcare, now a member of my portfolio.
With the health service under extraordinary pressure primarily due to the virus, Spire will be beneficiaries of that for a number of years.
Nothing is certain but a logical investment, I would say.
An article in the Guardian today “Private hospitals profit from NHS waiting lists” gives a good write up for Spire Healthcare.
https://www.theguardian.com/society/2021/sep/18/private-hospitals-profit-from-nhs-waiting-lists-as-people-without-insurance-pay-out
Things are looking really positive for the company with profit &reducing debt . I am really pleased Ramsey Health were unsuccessful in their bid, this company has the potential for a success story on its own IMO.
I had the good fortune to actually go to one of their hospitals recently.. what great medical and support staff they have, second to none Id say.
Its interesting reading back in their news that they have been buying scanners, which is where there is a big shortage in the UK nhs.
thats certainly i think going to be a big growth area, esp if the nhs want to catch up on their backlog.
all imo,
In my IG Morning Call email this morning:
Spire Healthcare raised to overweight at Barclays
Looking to the future
• Unprecedented demand. NHS waiting list continues to rise, supporting growth in self-pay
• Underlying performance strong, near term margins impacted by measures to maintain COVID-secure environment
• Actively managing down COVID costs within our control, but increased costs of staff absence and late notice patient cancellations in July and August as COVID levels increase
• Securing future workforce with 166 nurse degree apprentices recruited in Q2 21.
Really positive interview on Radio4 this morning. Talked about our H1 results, ncreasing revenue, increasing NHS numbers etc. All looking very good here. GLA
Really liking the fact that Tosca have added another 1.5%. Now at 16.9%. They voted down the takeover stating the price was too low.